紫光國微(002049.SZ)復牌跌6.61% 180億收購紫光聯盛100%股權未獲批准
格隆匯6月8日丨紫光國微(002049.SZ)今日復牌跳空下跌,半日收跌6.61%報68.08元,成交26.43億元,最新總市值413億元。公司昨晚公告,計劃以180億元購買紫光聯盛100%股權未獲得中國證監會審核通過。證監會認為:標的資產(紫光聯盛)權屬存在瑕疵,不符合《上市公司重大資產重組管理辦法》第十一條的規定;標的資產商譽金額佔比較大,申請人未能充分説明本次交易有利於提高上市公司資產質量,不符合《上市公司重大資產重組管理辦法》第四十三條的規定。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.